Canales-Ruiz, I. (., Martelli, M. (., Sehn, L. (. H., Vitolo, U. (., Nielsen, T. (. G., Sellam, G. (., . . . Kostakoglu, L. (. (2022). Baseline total metabolic tumor volume is prognostic for refractoriness to Iimunochemotherapy in DLBCL: Results from GOYA.
Citación estilo ChicagoCanales-Ruiz, I. (Irene)|||/items/a90dde96-9ef9-4994-8840-851258793345, M. (Mauricio)|||/items/a6d679d0-6c63-4e20-8236-e3483db90b03 Martelli, L.H. (Laura H.)|||/items/8c73dec6-a8b0-48d9-bdfe-c29f6c78affb Sehn, U. (Umberto)|||/items/8335cc7b-e868-44e3-8c75-27c5f7f78d18 Vitolo, T.G. (Tina G.)|||/items/4cca2474-652c-41e4-8725-0f55b404d1f9 Nielsen, G. (Gilla)|||/items/2c37a1d4-1e88-44c7-aa6f-87899e3775ff Sellam, A. (Alessia)|||/items/7afca8ed-325b-4868-a036-15c75e312526 Bottos, D. (Dirk)|||/items/b0e08286-dfa8-454a-b04d-3fc01634368a Klingbiel, y L. (Lale)|||/items/81de2cb9-9f5a-4251-8999-5c269eba5523 Kostakoglu. Baseline Total Metabolic Tumor Volume Is Prognostic for Refractoriness to Iimunochemotherapy in DLBCL: Results From GOYA. 2022.
Cita MLACanales-Ruiz, I. (Irene)|||/items/a90dde96-9ef9-4994-8840-851258793345, et al. Baseline Total Metabolic Tumor Volume Is Prognostic for Refractoriness to Iimunochemotherapy in DLBCL: Results From GOYA. 2022.